Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Health Tech and Transparency Revive the Struggling NHS?
Digital Health Can Health Tech and Transparency Revive the Struggling NHS?

The current state of NHS England has become a major concern for both policymakers and the public, as there are increasing calls for systemic reforms due to declining patient satisfaction. Workforce shortages, growing health inequalities, and burgeoning demand for long-term care have compounded the

Integrating Auriculotherapy with Wearables for Pain Relief and Wellness
Digital Health Integrating Auriculotherapy with Wearables for Pain Relief and Wellness

The fusion of ancient practices and modern technology is paving the way for innovative health solutions, bringing traditional Chinese medicine to the forefront of contemporary therapy. One notable example is the integration of auriculotherapy, a technique that has been practiced for centuries, with

How Is Korion Health Transforming At-Home Heart and Lung Screening?
Patient Care How Is Korion Health Transforming At-Home Heart and Lung Screening?

In a world where accessibility to healthcare is a persistent challenge, Korion Health stands out as a beacon of innovation and hope. Based in Pittsburgh, this startup is radically transforming how heart and lung screenings are conducted, moving critical health assessments from the clinical setting

Will the BIOSECURE Act Hinder Innovation in U.S. Biotechnology?
Regulatory & Compliance Will the BIOSECURE Act Hinder Innovation in U.S. Biotechnology?

Amid rising concerns over national security and economic self-reliance, the U.S. Congress has introduced the BIOSECURE Act. Aimed at curbing Chinese influence in the biotechnology sector, this legislation prevents companies with Chinese ties from accessing federal funding. While the Act promises

Labs Urge Lawmakers to Rescind FDA Rule on Lab-Developed Tests
Regulatory & Compliance Labs Urge Lawmakers to Rescind FDA Rule on Lab-Developed Tests

The call for legislative intervention to overturn the FDA's final rule on the regulation of laboratory-developed tests (LDTs) has intensified. The Association for Diagnostics and Laboratory Medicine (ADLM) has been at the forefront, urging lawmakers to take action against the FDA's new rule. This

Medtech VC Growth and IPOs Rise Amid M&A Slowdown in 2024
Infrastructure & Management Medtech VC Growth and IPOs Rise Amid M&A Slowdown in 2024

As the medtech sector navigates the financial intricacies of 2024, one can't help but notice the co-occurrence of rising venture capital (VC) investments and initial public offerings (IPOs), juxtaposed with a notable slowdown in mergers and acquisitions (M&A). This evolving landscape is reflective

Managing Cookies: User Data Control, Consent, and Website Security
Regulatory & Compliance Managing Cookies: User Data Control, Consent, and Website Security

As you browse the web, countless websites and their partners collect and process your personal data, primarily through the use of cookies, to enhance user experience and achieve various business objectives. These cookies serve multiple purposes, ranging from ensuring websites function correctly to

Female Physicians and Urban Areas Lead in Post-Pandemic Telehealth Use
Digital Health Female Physicians and Urban Areas Lead in Post-Pandemic Telehealth Use

Female Physicians and Urban Areas Lead in Post-Pandemic Telehealth Use The utilization of telehealth services has surged in the wake of the COVID-19 pandemic, driven by various factors including gender, geographical location, and medical specialty. According to a study published in Health Affairs,

Is the FTC Right in Opposing the Union and Terre Haute Hospitals Merger?
Regulatory & Compliance Is the FTC Right in Opposing the Union and Terre Haute Hospitals Merger?

The debate over the proposed merger of Union Hospital and Terre Haute Regional Hospital under Indiana’s Certificate of Public Advantage (COPA) law has drawn significant attention. The Federal Trade Commission (FTC) has pointed out several issues with the merger, critiquing potential increases in

Will New $3B Merger Revolutionize U.S. Healthcare Payment Integrity?
Infrastructure & Management Will New $3B Merger Revolutionize U.S. Healthcare Payment Integrity?

The healthcare sector in the U.S. has long grappled with inefficiencies and inaccuracies in payment processes. With a merger project valued at over $3 billion, private equity firm New Mountain Capital aims to address these challenges head-on. By combining The Rawlings Group, Apixio's Payment

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later